Roles of serum calcium, phosphorus, PTH and ALP on mortality in peritoneal dialysis patients: A nationwide, population-based longitudinal study using TWRDS 2005–2012

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Biomarkers of chronic kidney disease-mineral and bone disorder (CKD-MBD) correlate with morbidity and mortality in dialysis patients. However, the comparative roles of each CKD-MBD biomarker remained undetermined on long-term peritoneal dialysis (PD) patients. This retrospective study, employing a population-based database, aimed to evaluate the performance and provide the best evidence of each biomarker of CKD-MBD as predictor of all-cause mortality. Throughout the 8-year study period, total 12,116 PD patients were included in this study. Cox proportional regression and Kaplan-Meier method were used for survival analysis. For Cox regression model, baseline measurements and time-varying covariates were used for analysis. In Cox regression model using time-dependent covariates, serum calcium level of ?9.5 mg/dL was associated with increased mortality. For phosphorus, serum levels of either ?6.5 mg/dL or <3.5 mg/dL were associated with increased mortality. For parathyroid hormone (PTH), higher serum levels were not associated increased mortality. For alkaline phosphatase (ALP), mortality increased at levels ?100 IU/L. Our findings suggested that the detrimental effect of ALP on survival was more consistent, while serum calcium, phosphorus and PTH may have a less prominent effect on mortality. This study provided additional information for manipulating CKD-MBD biomarkers in PD patients.

Original languageEnglish
Article number33
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Peritoneal Dialysis
Parathyroid Hormone
Phosphorus
Alkaline Phosphatase
Longitudinal Studies
Chronic Kidney Disease-Mineral and Bone Disorder
Calcium
Mortality
Serum
Population
Biomarkers
Proportional Hazards Models
Survival Analysis
Dialysis
Retrospective Studies
Databases
Morbidity
Survival

ASJC Scopus subject areas

  • General

Cite this

@article{a5e50e57c30f47f98b453f0c1bc0e481,
title = "Roles of serum calcium, phosphorus, PTH and ALP on mortality in peritoneal dialysis patients: A nationwide, population-based longitudinal study using TWRDS 2005–2012",
abstract = "Biomarkers of chronic kidney disease-mineral and bone disorder (CKD-MBD) correlate with morbidity and mortality in dialysis patients. However, the comparative roles of each CKD-MBD biomarker remained undetermined on long-term peritoneal dialysis (PD) patients. This retrospective study, employing a population-based database, aimed to evaluate the performance and provide the best evidence of each biomarker of CKD-MBD as predictor of all-cause mortality. Throughout the 8-year study period, total 12,116 PD patients were included in this study. Cox proportional regression and Kaplan-Meier method were used for survival analysis. For Cox regression model, baseline measurements and time-varying covariates were used for analysis. In Cox regression model using time-dependent covariates, serum calcium level of ?9.5 mg/dL was associated with increased mortality. For phosphorus, serum levels of either ?6.5 mg/dL or <3.5 mg/dL were associated with increased mortality. For parathyroid hormone (PTH), higher serum levels were not associated increased mortality. For alkaline phosphatase (ALP), mortality increased at levels ?100 IU/L. Our findings suggested that the detrimental effect of ALP on survival was more consistent, while serum calcium, phosphorus and PTH may have a less prominent effect on mortality. This study provided additional information for manipulating CKD-MBD biomarkers in PD patients.",
author = "Liu, {Chung Te} and Lin, {Yen Chung} and Lin, {Yi Chun} and Kao, {Chih Chin} and Chen, {Hsi Hsien} and Hsu, {Chih Cheng} and Wu, {Mai Szu}",
year = "2017",
month = "1",
day = "1",
doi = "10.1038/s41598-017-00080-4",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Roles of serum calcium, phosphorus, PTH and ALP on mortality in peritoneal dialysis patients

T2 - A nationwide, population-based longitudinal study using TWRDS 2005–2012

AU - Liu, Chung Te

AU - Lin, Yen Chung

AU - Lin, Yi Chun

AU - Kao, Chih Chin

AU - Chen, Hsi Hsien

AU - Hsu, Chih Cheng

AU - Wu, Mai Szu

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Biomarkers of chronic kidney disease-mineral and bone disorder (CKD-MBD) correlate with morbidity and mortality in dialysis patients. However, the comparative roles of each CKD-MBD biomarker remained undetermined on long-term peritoneal dialysis (PD) patients. This retrospective study, employing a population-based database, aimed to evaluate the performance and provide the best evidence of each biomarker of CKD-MBD as predictor of all-cause mortality. Throughout the 8-year study period, total 12,116 PD patients were included in this study. Cox proportional regression and Kaplan-Meier method were used for survival analysis. For Cox regression model, baseline measurements and time-varying covariates were used for analysis. In Cox regression model using time-dependent covariates, serum calcium level of ?9.5 mg/dL was associated with increased mortality. For phosphorus, serum levels of either ?6.5 mg/dL or <3.5 mg/dL were associated with increased mortality. For parathyroid hormone (PTH), higher serum levels were not associated increased mortality. For alkaline phosphatase (ALP), mortality increased at levels ?100 IU/L. Our findings suggested that the detrimental effect of ALP on survival was more consistent, while serum calcium, phosphorus and PTH may have a less prominent effect on mortality. This study provided additional information for manipulating CKD-MBD biomarkers in PD patients.

AB - Biomarkers of chronic kidney disease-mineral and bone disorder (CKD-MBD) correlate with morbidity and mortality in dialysis patients. However, the comparative roles of each CKD-MBD biomarker remained undetermined on long-term peritoneal dialysis (PD) patients. This retrospective study, employing a population-based database, aimed to evaluate the performance and provide the best evidence of each biomarker of CKD-MBD as predictor of all-cause mortality. Throughout the 8-year study period, total 12,116 PD patients were included in this study. Cox proportional regression and Kaplan-Meier method were used for survival analysis. For Cox regression model, baseline measurements and time-varying covariates were used for analysis. In Cox regression model using time-dependent covariates, serum calcium level of ?9.5 mg/dL was associated with increased mortality. For phosphorus, serum levels of either ?6.5 mg/dL or <3.5 mg/dL were associated with increased mortality. For parathyroid hormone (PTH), higher serum levels were not associated increased mortality. For alkaline phosphatase (ALP), mortality increased at levels ?100 IU/L. Our findings suggested that the detrimental effect of ALP on survival was more consistent, while serum calcium, phosphorus and PTH may have a less prominent effect on mortality. This study provided additional information for manipulating CKD-MBD biomarkers in PD patients.

UR - http://www.scopus.com/inward/record.url?scp=85029476803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029476803&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-00080-4

DO - 10.1038/s41598-017-00080-4

M3 - Review article

AN - SCOPUS:85029476803

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 33

ER -